Table 3.
Associations of subclinical cardiac organ damage in the total study cohort.
| Univariable Analyses | Multivariable Analyses | |||
|---|---|---|---|---|
| OR (95% CI) | p | OR (95% CI) | p | |
| Psoriasis | 0.39 (0.19–0.78) | 0.008 | 0.32 (0.13–0.77) | 0.01 |
| Age, years | 1.04 (1.01–1.08) | 0.005 | 1.04 (1.00–1.07) | 0.05 |
| Female sex | 2.67 (1.17–6.11) | 0.02 | 5.15 (1.72–14.40) | 0.003 |
| Current smoking | 0.33 (0.15–0.74) | 0.006 | 0.51 (0.20–1.33) | 0.17 |
| Hypertension | 2.21 (1.08–4.52) | 0.03 | 1.81 (0.75–4.37) | 0.19 |
| Body mass index, kg/m2 | 1.07 (0.99–1.16) | 0.10 | 1.06 (0.96–1.17) | 0.22 |
| Obesity | 1.67 (0.80–3.46) | 0.18 | ||
| Diabetes | 4.29 (0.51–36.03) | 0.18 | ||
| Anti-hypertensive treatment | 2.57 (1.04–6.38) | 0.04 | ||
| LDL cholesterol, mmol/L | 1.28 (0.88–1.86) | 0.20 | ||
| Statin, n (%) | 1.99 (0.35–2.88) | 1.00 | ||
CI: Confidence interval; LDL: Low density lipoprotein; OR: Odds ratio.